Health & Life CoROCO:1781 49 OCF Yield % is 0.56 as of Jul. 12, 2026. GuruFocus rates ROCO:1781 with a GF Score™ of 49/100 and a GF Value™ of NT$8.73 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Health & Life Co ranks worse than 55.52% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Health & Life Co's OCF Yield % or its related term are showing as below:
ROCO:1781'
s OCF Yield % Range Over the Past 10 Years
Min: -24.82 Med: -3.04 Max: 15.99
Current: 0.56
During the past 13 years, the highest OCF Yield % of Health & Life Co was 15.99%. The lowest was -24.82%. And the median was -3.04%.
ROCO:1781's OCF Yield % is ranked worse than 55.52% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.7
vs ROCO:1781: 0.56
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Health & Life Co OCF Yield % Related Terms
Health & Life Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Health & Life Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1781 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Health & Life Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health & Life Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Health & Life Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Health & Life Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health & Life Co (ROCO:1781) has a OCF Yield % of 0.56 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Health & Life Co and its competitors. According to the industry distribution chart, Health & Life Co ranks #473 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 55.5%.
Is Health & Life Co's OCF Yield % too high?
Health & Life Co's current OCF Yield % is 0.56. The Medical Devices & Instruments industry median OCF Yield % is 1.70. Health & Life Co's value of 0.56 is 67.1% below this industry median. Based on the distribution chart, Health & Life Co ranks #473 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Health & Life Co has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Health & Life Co's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Health & Life Co ranks #473 out of 852 companies for OCF Yield %. This places Health & Life Co in the lower half of its industry. The industry median OCF Yield % is 1.70. Health & Life Co's value of 0.56 is 67.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.70, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health & Life Co's current OCF Yield % of 0.56 is 67.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Health & Life Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health & Life Co's current OCF Yield % is 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health & Life Co stock overvalued right now?
Based on GuruFocus' analysis, Health & Life Co (ROCO:1781) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$8.73, compared to a current price of NT$11.95 — trading 36.9% above its estimated fair value. The current OCF Yield % is 0.56 and 67.1% below the Medical Devices & Instruments industry median of 1.70. Health & Life Co's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Health & Life Co (ROCO:1781), the current OCF Yield % is 0.56 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health & Life Co (ROCO:1781) Overvalued in 2026?
Based on GuruFocus' analysis, Health & Life Co stock appears to be overvalued.
The current stock price of NT$11.95 is trading 36.9% above its estimated GF Value™ of NT$8.73.
GuruFocus considers Health & Life Co to be Significantly Overvalued.
Key valuation signals for ROCO:1781:
OCF Yield %: 0.56
GF Value™: NT$8.73 vs. price of NT$11.95 (36.9% above fair value)
Industry Position: 67.1% below the Medical Devices & Instruments median (#473 of 852)
No single metric tells the full story. See the ROCO:1781 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.
49GF Score
Get the complete analysis for ROCO:1781
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1781 has been successfully added to your 
